PEL, a 'new' high-frequency red cell surface antigen. 1996

G L Daniels, and H Simard, and M Goldman, and V Taliano, and M Fleury, and F Decary, and G Spurll, and C Garcia, and P Ouellet
MRC Blood Group Unit, London, UK.

A 'new', inherited, high-frequency blood group antigen has been named PEL and is numbered 901014. Two PEL-propositi with anti-PEL have been found, both French-Canadians. Two other French-Canadian propositi with very weak expression of PEL on their red cells have an antibody, provisionally named anti-MTP, which does not react with PEL-cells.

UI MeSH Term Description Entries
D002170 Canada The largest country in North America, comprising 10 provinces and three territories. Its capital is Ottawa.
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000954 Antigens, Surface Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated. Cell Surface Antigens,Surface Antigens,Surface Markers, Immunological,Cell Surface Antigen,Immunologic Surface Markers,Markers, Immunological Surface,Surface Antigen,Surface Markers, Immunologic,Antigen, Cell Surface,Antigen, Surface,Antigens, Cell Surface,Immunological Surface Markers,Markers, Immunologic Surface,Surface Antigen, Cell,Surface Antigens, Cell

Related Publications

G L Daniels, and H Simard, and M Goldman, and V Taliano, and M Fleury, and F Decary, and G Spurll, and C Garcia, and P Ouellet
January 1994, Vox sanguinis,
G L Daniels, and H Simard, and M Goldman, and V Taliano, and M Fleury, and F Decary, and G Spurll, and C Garcia, and P Ouellet
January 1983, Vox sanguinis,
G L Daniels, and H Simard, and M Goldman, and V Taliano, and M Fleury, and F Decary, and G Spurll, and C Garcia, and P Ouellet
January 1978, Vox sanguinis,
G L Daniels, and H Simard, and M Goldman, and V Taliano, and M Fleury, and F Decary, and G Spurll, and C Garcia, and P Ouellet
January 1998, Immunohematology,
G L Daniels, and H Simard, and M Goldman, and V Taliano, and M Fleury, and F Decary, and G Spurll, and C Garcia, and P Ouellet
January 1987, Transfusion,
G L Daniels, and H Simard, and M Goldman, and V Taliano, and M Fleury, and F Decary, and G Spurll, and C Garcia, and P Ouellet
February 1982, Journal of immunogenetics,
G L Daniels, and H Simard, and M Goldman, and V Taliano, and M Fleury, and F Decary, and G Spurll, and C Garcia, and P Ouellet
January 1994, Vox sanguinis,
G L Daniels, and H Simard, and M Goldman, and V Taliano, and M Fleury, and F Decary, and G Spurll, and C Garcia, and P Ouellet
January 1988, Vox sanguinis,
G L Daniels, and H Simard, and M Goldman, and V Taliano, and M Fleury, and F Decary, and G Spurll, and C Garcia, and P Ouellet
January 1984, Hybridoma,
G L Daniels, and H Simard, and M Goldman, and V Taliano, and M Fleury, and F Decary, and G Spurll, and C Garcia, and P Ouellet
January 2014, Transfusion medicine reviews,
Copied contents to your clipboard!